C. Malvestutto

发表

Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial.

G. Bloomfield, M. Kozal, K. Tashima, 2020, The Journal of infectious diseases.

Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE).

Michael T. Lu, C. Fichtenbaum, P. Douglas, 2019, American heart journal.

Prevalence and characteristics of hepatitis C virus coinfection in a human immunodeficiency virus clinical trials group: the Terry Beirn Community Programs for Clinical Research on AIDS.

K. H. Hullsiek, R. Arduino, E. Tedaldi, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Asymptomatic SARS-CoV-2 Infection Is Common Among ART-Treated People With HIV

G. Bloomfield, C. Fichtenbaum, P. Douglas, 2022, Journal of acquired immune deficiency syndromes.

COVID-19 Vaccination Rates in a Global HIV Cohort.

Michael T. Lu, C. Fichtenbaum, P. Douglas, 2021, The Journal of infectious diseases.

Gut Microbiota, Plasma Metabolomic Profiles, and Carotid Artery Atherosclerosis in HIV Infection

M. Budoff, K. Anastos, Steven Wolinsky, 2022, Arteriosclerosis, thrombosis, and vascular biology.

Rationale and Design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) RCT# NCT02344290

Michael T. Lu, U. Hoffmann, J. Currier, 2019 .

The Evolving Landscape of ASCVD Risk Among Patients With HIV.

C. Malvestutto, 2022, The Journal of family practice.

Coronary heart disease in people infected with HIV

J. Aberg, C. Malvestutto, Carlos D. Malvestutto, 2010, Cleveland Clinic Journal of Medicine.

Evidence Based Scarce Resource Allocation During the COVID-19 Pandemic: A Case Study of Bamlanivimab Administration in the Emergency Department

N. Kman, M. Lustberg, C. Malvestutto, 2022, Hospital pharmacy.

Syringe Service Program Utilization, Barriers, and Preferences for Design in Rural Appalachia: Differences between Men and Women Who Inject Drugs

J. Bridges, H. Cooper, Christopher R. Browning, 2020, Substance use & misuse.

In Vitro Exposure of Leukocytes to HIV Preexposure Prophylaxis Decreases Mitochondrial Function and Alters Gene Expression Profiles

M. Lederman, M. Cameron, S. Koletar, 2020, Antimicrobial Agents and Chemotherapy.

Challenges Facing a Rural Opioid Epidemic: Treatment and Prevention of HIV and Hepatitis C

W. Miller, C. Hurt, Jessica Barrett, 2018, Current HIV/AIDS Reports.

Commentary on Fraser et al. (2018): Evidence base for harm reduction services-the urban-rural divide.

W. Miller, V. Go, K. Lancaster, 2018, Addiction.

Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19

Karen L. Price, A. Perelson, R. Ribeiro, 2022, Nature Communications.

Bamlanivimab reduces nasopharyngeal SARS-CoV-2 RNA levels but not symptom duration in non-hospitalized adults with COVID-19

A. Perelson, M. Hughes, W. Fischer, 2021, medRxiv.

The impact of hepatitis C virus coinfection on HIV-related kidney disease: a systematic review and meta-analysis

P. Klotman, C. Parikh, S. Coca, 2008, AIDS.

Chronic kidney disease in HIV infection: an urban epidemic

I. Barash, P. Klotman, A. Cohen, 2007, AIDS.

HIV and Dyslipidemia

J. Aberg, C. Malvestutto, Carlos D. Malvestutto, 2020, Contemporary Cardiology.

Efficacy and safety of CD24Fc in hospitalised patients with COVID-19: a randomised, double-blind, placebo-controlled, phase 3 study

Yang Liu, S. Koletar, J. Lake, 2022, The Lancet Infectious Diseases.

Outpatient Use of Monoclonal Antibodies in Pregnant Individuals With Mild or Moderate Coronavirus Disease 2019 (COVID-19)

M. Landon, K. Rood, M. Costantine, 2022, Obstetrics and gynecology.

Tuberculous Gastric Abscess in a Patient with AIDS: A Rare Presentation

C. Malvestutto, J. Torres, Ekta Nayyar, 2016, Case reports in infectious diseases.

A Collaborative Intervention Between Emergency Medicine and Infectious Diseases to Increase Syphilis and HIV Screening in the Emergency Department

S. Koletar, J. Bazan, M. Lustberg, 2021, Sexually transmitted diseases.

Management of lipid disorders in patients living with HIV

M. Myerson, J. Aberg, C. Malvestutto, 2015, Journal of clinical pharmacology.

The importance of methods for site performance evaluation in REPRIEVE, a longitudinal, global, multicenter trial

C. Fichtenbaum, J. Aberg, S. Grinspoon, 2022, Contemporary clinical trials.

Assessment of Obesity and Cardiometabolic Status by Integrase Inhibitor Use in REPRIEVE: A Propensity-Weighted Analysis of a Multinational Primary Cardiovascular Prevention Cohort of People With Human Immunodeficiency Virus

C. Fichtenbaum, P. Douglas, J. Currier, 2021, Open forum infectious diseases.

Identification of pre-infection markers and differential plasma protein expression following SARS-CoV-2 infection in people living with HIV

C. Fichtenbaum, J. Currier, J. Aberg, 2023, eBioMedicine.

Challenges of Statins in HIV Hyperlipidemia

J. Aberg, C. Malvestutto, Carlos D. Malvestutto, 2013 .

Management of dyslipidemia in HIV-infected patients.

J. Aberg, C. Malvestutto, Carlos D. Malvestutto, 2011, Clinical lipidology.

Sex Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation Among People With Human Immunodeficiency Virus in the United States

Michael T. Lu, G. Bloomfield, C. Fichtenbaum, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Ideal cardiovascular health, biomarkers, and coronary artery disease in persons with HIV

Michael T. Lu, G. Bloomfield, C. Fichtenbaum, 2022, AIDS.

Lack of Pharmacokinetic Interactions Between Pitavastatin and Efavirenz or Darunavir/Ritonavir

J. Aberg, James A. Underberg, G. Morse, 2014, Journal of acquired immune deficiency syndromes.

Successful recruitment of a multi-site international randomized placebo-controlled trial in people with HIV with attention to diversity of race and ethnicity: critical role of central coordination

A. Rancourt, C. Fichtenbaum, P. Douglas, 2020, HIV research & clinical practice.

TREATMENT WITH SOLUBLE CD24 ATTENUATES COVID-19-ASSOCIATED SYSTEMIC IMMUNOPATHOLOGY

Dongjun Chung, C. Bolyard, Qin Ma, 2021, Journal of Hematology & Oncology.

Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular Prevention

Michael T. Lu, C. Fichtenbaum, P. Douglas, 2021, JAMA network open.

TREATMENT WITH SOLUBLE CD24 ATTENUATES COVID-19-ASSOCIATED SYSTEMIC IMMUNOPATHOLOGY

Dongjun Chung, Mohammad Yusuf, C. Bolyard, 2021, medRxiv.

Weight Gain in People with HIV: The role of demographics, antiretroviral therapy, and lifestyle factors on weight.

M. Lustberg, C. Malvestutto, Sheila Okere, 2023, AIDS research and human retroviruses.

Associations of Muscle Density and Area With Coronary Artery Plaque and Physical Function

C. Fichtenbaum, P. Sax, D. Haas, 2023, Journal of acquired immune deficiency syndromes.

Associations Between HIV Serostatus and Cardiac Structure and Function Evaluated by 2‐Dimensional Echocardiography in the Multicenter AIDS Cohort Study

Katherine C. Wu, M. Budoff, J. Lima, 2021, Journal of the American Heart Association.

Cytomegalovirus IgG is Associated With Physical Function But Not Muscle Density in People With HIV

C. Fichtenbaum, T. Burdo, H. Ribaudo, 2024, Journal of acquired immune deficiency syndromes.

Risk of COVID-19 after natural infection or vaccination

Nicole L. Nollen, Eric A. Meyerowitz, Waseem M. Chughtai, 2023, EBioMedicine.